Launch evidence is thin
UAT is close, but test coverage, defect aging, release criteria, and owner signoff are not clean enough for approval-ready review.
Scenario
The starting point
A delivery effort is approaching launch with status marked green, but the evidence behind readiness is uneven. The goal is to turn the launch conversation into a traceable review of blockers, control exposure, signoff gaps, and benefit assumptions.
Blockers need ownership
A launch blocker is visible, but accountability is spread across delivery, operations, security, and sponsor teams.
Value needs a baseline
A benefit claim is plausible, but baseline measures, assumptions, and post-launch evidence are not yet strong enough for value realization review.
Module route
How the work moves
The journey uses five public modules. Each module names the evidence it needs, the evidence it produces, and the decisions that stay with accountable humans.
1. Confirm launch readiness
Release Readiness and UAT Governance Pack checks UAT scope, acceptance evidence, defects, launch criteria, and signoff posture.
Open Release Readiness and UAT Governance Pack
2. Surface control exposure
Controls and Exposure Governance Toolkit frames the control issue, exposure path, decision owner, and acceptable response options.
Open Controls and Exposure Governance Toolkit
3. Keep governance trace
PMO Governance Operations Log records blockers, decisions, approvals, escalations, and unresolved follow-up items.
Open PMO Governance Operations Log
4. Test the value claim
Value Realization Governance Ledger links claimed benefits to baselines, assumptions, measures, review dates, and confidence.
Open Value Realization Governance Ledger
5. Package final review
Executive Portfolio Review Pack Builder turns readiness evidence, blockers, value assumptions, and human decisions into an executive-ready view.
Open Executive Portfolio Review Pack Builder
Synthetic input
Delivery readiness inputs
These inputs are synthetic. They are designed to show how delivery readiness can be reviewed without relying on optimistic status language.
| Input | Initial signal | Evidence gap | Governance route |
|---|---|---|---|
| Release approaching UAT with weak evidence | Delivery status is green and UAT start is scheduled. | Test scope, acceptance criteria, defect threshold, and signoff owners are incomplete. | Release readiness review before UAT gate. |
| Launch blocker with unclear owner | A dependency issue could delay launch. | No accountable owner has accepted the blocker, decision path, or escalation route. | Governance log entry with owner assignment and executive escalation if needed. |
| Control exposure needing human decision | A control exception may be acceptable for launch with mitigation. | Exposure level, compensating control, approval threshold, and risk owner are not confirmed. | Controls exposure review and documented decision options. |
| Benefit claim with missing baseline | Sponsor expects cycle-time improvement after launch. | Current cycle time, measurement method, review date, and assumption owner are missing. | Value realization ledger before benefits claim is accepted. |
Evidence produced
What the journey creates
The evidence is meant to support better approval conversations. It gives leaders a clean view of readiness, confidence, gaps, and decisions.
Readiness evidence
- UAT scope, acceptance criteria, defect status, and launch criteria.
- Named signoff owners for business, delivery, operations, security, and support.
- Readiness confidence based on evidence quality, not status color.
- Gate recommendation with assumptions and unresolved gaps.
Blocker and exposure evidence
- Launch blocker owner, impact, age, decision path, and escalation date.
- Control exposure summary with response options and approval threshold.
- Human decision required, with named accountable role.
- Open follow-up register for items that cannot be closed during the review.
Value evidence
- Benefit claim, baseline measure, measurement method, and review date.
- Assumption owner and confidence level for each claimed outcome.
- Post-launch evidence needed before benefit realization is accepted.
- Clear separation between launch approval and value confirmation.
Executive review evidence
- Readiness state, blockers, signoff gaps, and value assumptions.
- Evidence confidence for launch, control, and benefit dimensions.
- Decision agenda with owner, due date, and approval forum.
- Public-safe narrative that keeps synthetic examples separate from real operations.
Final review
Delivery readiness review view
The final view lets leaders approve, delay, escalate, or ask for more evidence without having to infer readiness from a green dashboard cell.
Decision frame
The launch can move toward UAT only after readiness evidence is strengthened, blocker ownership is accepted, control exposure receives a human decision, and the benefit claim is tied to a measurable baseline.
| Readiness state | Blockers | Signoff gaps | Value assumptions | Evidence confidence | Human decisions required |
|---|---|---|---|---|---|
| UAT start is conditionally ready. | One launch dependency could affect test environment availability. | Business owner and operations support signoff are not complete. | Launch approval assumes representative UAT coverage and stable support staffing. | Moderate after UAT evidence is updated; low before acceptance criteria are confirmed. | Approve UAT start conditions and name signoff owners. |
| Launch readiness is not yet approved. | Blocker owner is unclear and escalation path is incomplete. | Security approval depends on exposure decision. | Benefit timing assumes the blocker is resolved before launch window closes. | Low until ownership, mitigation, and decision timing are documented. | Assign blocker owner, escalation forum, and launch decision date. |
| Control exposure requires review. | Potential exception may require mitigation during launch window. | Risk owner and approval threshold are not named. | Value claim assumes no material rework from the exposure response. | Moderate for exposure description; low for approval posture. | Accept, mitigate, delay, or escalate the control exposure. |
| Benefits review is not ready. | No delivery blocker, but measurement ownership is missing. | Sponsor has not approved baseline, measure, or review cadence. | Cycle-time improvement depends on adoption, process compliance, and clean baseline data. | Low until baseline and post-launch review plan are approved. | Name value owner and approve baseline before claiming benefit realization. |
Repository route
Where to inspect the modules
The journey summarizes the route. The repositories hold the operating details, examples, public-safe boundaries, and review patterns.